NIH-funded research R21 grant

Understanding how specific B cells help fight viral infections

Official title: The Role of Tbet+ B cells in viral reinfection

Funded at Rutgers Biomedical and Health Sciences · NIH-11119534 · Data updated 2026-11-12

This study is looking at a special type of B cell that helps your body fight off viruses, to see how they develop and make antibodies that keep you safe from getting sick again, which could help us understand immune responses better for everyone, including those with autoimmune conditions.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startJune 11, 2025
Project endMay 31, 2027
Funding year2025
Award (this year)$416,121
NIH project number1R21AI190857-01
Project IDNIH-11119534 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have experienced viral infections and may be at risk for reinfection, particularly those with autoimmune conditions.

Less likely to help

Patients who have not had viral infections or those with unrelated health conditions may not benefit from this research.

What this research studies

This research investigates the role of a unique subset of B cells, known as Tbet+ B cells, in the immune response to viral infections. It focuses on how these B cells mature and differentiate to produce antibodies that protect against reinfection. By examining the mechanisms behind their activation and function, the study aims to clarify their contribution to generating effective anti-viral antibodies. This could lead to better understanding of immune responses in both healthy individuals and those with autoimmune conditions.

Why it matters

Potential benefit: If successful, this research could enhance our understanding of immune responses, potentially leading to improved treatments for viral infections and autoimmune diseases.

How similar studies have gone: Previous studies have shown that understanding specific B cell functions can lead to significant advancements in vaccine development and treatment strategies, indicating a promising avenue for this research.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: Weinstein, Jason — Rutgers Biomedical and Health Sciences
  • Study coordinator: Weinstein, Jason

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.